Exact Mass: 267.1826

Exact Mass Matches: 267.1826

Found 212 metabolites which its exact mass value is equals to given mass value 267.1826, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Metoprolol

1-[4-(2-methoxyethyl)phenoxy]-3-[(propan-2-yl)amino]propan-2-ol

C15H25NO3 (267.1834)


Metoprolol is a selective beta1 receptor blocker used in treatment of several diseases of the cardiovascular system. It is marketed under the brand name Lopressor by Novartis, and Toprol (in the USA); Seleken or Selokeen (elsewhere); A selective adrenergic beta-1-blocking agent with no stimulatory action. Its binding to plasma albumin is weaker than alprenolol and it may be useful in the treatment of several diseases of the cardiovascular system; Metoprolol is a selective beta1 receptor blocker used in treatment of several diseases of the cardiovascular system. It is marketed under the brand name Lopressor by Novartis, and Toprol (in the USA); Seleken or Selokeen (elsewhere); as Minax by Alphapharm (in Australia), as Betaloc by AstraZeneca and as Corvitol by Berlin-Chemie AG; A selective adrenergic beta-1-blocking agent with no stimulatory action. Its binding to plasma albumin is weaker than alprenolol and it may be useful in angina pectoris, hypertension, or cardiac arrhythmias; as Minax by Alphapharm (in Australia), as Betaloc by AstraZeneca and as Corvitol by Berlin-Chemie AG. C - Cardiovascular system > C07 - Beta blocking agents > C07A - Beta blocking agents > C07AB - Beta blocking agents, selective C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013565 - Sympatholytics D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents Metoprolol is an orally active, selective β1-adrenoceptor antagonist. Metoprolol shows anti-inflammation, antitumor and anti-angiogenic properties[1][2][3].

   

Ergine

Ergoline-8-carboxamide, 9,10-didehydro-6-methyl-, (8.beta.)-

C16H17N3O (267.1372)


   

Codonopsine

(2R,3R,4R,5R)-2-(3,4-dimethoxyphenyl)-1,5-dimethyl-pyrrolidine-3,4-diol

C14H21NO4 (267.1471)


   

NSC-608986

Elaeocarpidine

C17H21N3 (267.1735)


   

Diethofencarb

Pesticide3_Diethofencarb_C14H21NO4_Powmil

C14H21NO4 (267.1471)


   

Auramine

4-[4-(dimethylamino)benzenecarboximidoyl]-N,N-dimethylaniline

C17H21N3 (267.1735)


D000890 - Anti-Infective Agents D004396 - Coloring Agents D004202 - Disinfectants

   

Allopumiliotoxin 267A

Allopumiliotoxin 267A

C16H29NO2 (267.2198)


   

4-(Diphenylmethoxy)piperidine

4-(Diphenylmethoxy)piperidine

C18H21NO (267.1623)


   

4-(Diphenylmethoxy)piperidine

4-(Diphenylmethoxy)piperidine

C18H21NO (267.1623)


   

4-Tert-butyl-N-methyl-N-phenylbenzamide

Antigens, leukemia, common acute lymphoblastic

C18H21NO (267.1623)


   

Desacetylmetipranolol

1-(2,3,5-Trimethyl-4-hydroxyphenoxy)-3-isopropylamino-2-propanol hydrochloride

C15H25NO3 (267.1834)


   

3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,4,6-trimethyl-, diethyl ester

3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,4,6-trimethyl-, diethyl ester

C14H21NO4 (267.1471)


   

Azacyclonol

diphenyl(piperidin-4-yl)methanol

C18H21NO (267.1623)


C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent Azacyclonol (γ-pipradol), a metabolite of Terfenadine, is a central depressant agent. Azacyclonol is a ganglion-blocking agent. Azacyclonol can be used to diminish psychoses-induced hallucinations[1][2][3].

   

Butaxamine

2-(tert-butylamino)-1-(2,5-dimethoxyphenyl)propan-1-ol

C15H25NO3 (267.1834)


D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013565 - Sympatholytics D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D057847 - Lipid Regulating Agents > D000960 - Hypolipidemic Agents D009676 - Noxae > D000963 - Antimetabolites D007004 - Hypoglycemic Agents

   

Carbuterol

N-{5-[2-(tert-butylamino)-1-hydroxyethyl]-2-hydroxyphenyl}carbamimidic acid

C13H21N3O3 (267.1583)


R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03C - Adrenergics for systemic use > R03CC - Selective beta-2-adrenoreceptor agonists R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03A - Adrenergics, inhalants > R03AC - Selective beta-2-adrenoreceptor agonists C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist

   

Lysergic acid amide

6-methyl-6,11-diazatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),2,9,12,14-pentaene-4-carboxamide

C16H17N3O (267.1372)


   

Metoprolol acid

2-(4-{2-hydroxy-3-[(propan-2-yl)amino]propoxy}phenyl)acetic acid

C14H21NO4 (267.1471)


   

Russian VX

2-methylpropyl {[2-(diethylamino)ethyl]sulfanyl}(methyl)phosphinate

C11H26NO2PS (267.1422)


   

Diethyl 2,3,4-trimethyl-2,3-dihydropyridine-5,6-dicarboxylate

2,3-Diethyl 4,5,6-trimethyl-5,6-dihydropyridine-2,3-dicarboxylic acid

C14H21NO4 (267.1471)


   

O-Ethyl S-(2-diisopropylaminoethyl) methylphosphonothioate

Methylphosphonothioic acid S-(2-(bis(1-methylethyl)amino)ethyl) O-ethyl ester

C11H26NO2PS (267.1422)


VX nerve agent, also known as VX, belongs to the class of organic compounds known as trialkylamines. These are organic compounds containing a trialkylamine group, characterized by exactly three alkyl groups bonded to the amino nitrogen. Based on a literature review a significant number of articles have been published on VX nerve agent. This compound has been identified in human blood as reported by (PMID: 31557052 ). O-ethyl s-(2-diisopropylaminoethyl) methylphosphonothioate is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically O-Ethyl S-(2-diisopropylaminoethyl) methylphosphonothioate is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. VX is an extremely toxic synthetic chemical compound in the organophosphorus class, specifically, a thiophosphonate. In the class of nerve agents, it was developed for military use in chemical warfare after translation of earlier discoveries of organophosphate toxicity in pesticide research. In its pure form, VX is an oily, relatively non-volatile liquid that is amber-like in colour.[4] Because of its low volatility, VX persists in environments where it is dispersed.[5][6] VX, short for "venomous agent X",[7] is one of the best known of the V nerve agents and originated from pesticide development work at Imperial Chemical Industries (ICI). It was developed further at Porton Down in England during the early 1950s,[8] based on research first done by Gerhard Schrader, a chemist working for IG Farben in Germany during the 1930s.[citation needed] It is now one of a broader V-series of agents which are classified as nerve agents. VX has been allegedly used in warfare and has been used in several assassinations. The brother of North Korean leader Kim Jong Un, Kim Jong Nam, had the substance thrown in his face in Kuala Lumpur International Airport on the 13th February 2017 by two women. He died being rushed to hospital approximately 15 minutes later. The substance is extremely deadly; VX fatalities occur with exposure to tens of milligram quantities via inhalation or absorption through skin; VX is more potent than sarin, another nerve agent with a similar mechanism of action. On such exposure, these agents severely disrupt the body's signaling between the nervous and muscular systems, leading to a prolonged neuromuscular blockade, flaccid paralysis of all the muscles in the body including the diaphragm, and death by asphyxiation.[9] The danger of VX, in particular, lies in direct exposure to the chemical agent persisting where it was dispersed, and not through its evaporating and being distributed as a vapor; it is not considered a vapor hazard due to its relative non-volatility. VX is considered an area denial weapon due to these physical and biochemical characteristics.[10] As a chemical weapon, it is categorized as a weapon of mass destruction by the United Nations and is banned by the Chemical Weapons Convention of 1993,[11] where production and stockpiling of VX exceeding 100 grams (3.53 oz) per year is outlawed. The only exception is for "research, medical or pharmaceutical purposes outside a single small-scale facility in aggregate quantities not exceeding 10 kg (22 lb) per year per facility".[12]

   

Diethyl 2,4,6-trimethyl-3,4-dihydropyridine-3,5-dicarboxylate

3,5-Diethyl 2,4,6-trimethyl-3,4-dihydropyridine-3,5-dicarboxylic acid

C14H21NO4 (267.1471)


   

metoprolol

metoprolol

C15H25NO3 (267.1834)


C - Cardiovascular system > C07 - Beta blocking agents > C07A - Beta blocking agents > C07AB - Beta blocking agents, selective C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013565 - Sympatholytics D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents CONFIDENCE standard compound; EAWAG_UCHEM_ID 172 Metoprolol is an orally active, selective β1-adrenoceptor antagonist. Metoprolol shows anti-inflammation, antitumor and anti-angiogenic properties[1][2][3].

   

Erginine

Isolysergic acid amide

C16H17N3O (267.1372)


   

Haplacutine E

Haplacutine E

C18H21NO (267.1623)


   

Azacyclonol

4-Piperidinemethanol, a,a-diphenyl-

C18H21NO (267.1623)


C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent Azacyclonol (γ-pipradol), a metabolite of Terfenadine, is a central depressant agent. Azacyclonol is a ganglion-blocking agent. Azacyclonol can be used to diminish psychoses-induced hallucinations[1][2][3].

   

Metoprolol acid

Metoprolol acid

C14H21NO4 (267.1471)


   

2-(5-tert-Butyl-2-hydroxyphenyl)benzotriazole

2-(5-tert-Butyl-2-hydroxyphenyl)benzotriazole

C16H17N3O (267.1372)


   

Pipradrol

Pipradrol

C18H21NO (267.1623)


N - Nervous system > N06 - Psychoanaleptics > N06B - Psychostimulants, agents used for adhd and nootropics C78272 - Agent Affecting Nervous System > C47795 - CNS Stimulant

   

DDC (porphyrinogen)

DDC (porphyrinogen)

C14H21NO4 (267.1471)


   
   

N-(p-Hydroxyphenethyl)actinidine

N-(p-Hydroxyphenethyl)actinidine

C18H21NO (267.1623)


   

Brevicarine

Brevicarine

C17H21N3 (267.1735)


Origin: Plant; SubCategory_DNP: Alkaloids derived from tryptophan, beta-Carboline alkaloids, Indole alkaloids

   

deca-2Z,8Z-dien-6-yn-1-oic acid phenylethylamide

deca-2Z,8Z-dien-6-yn-1-oic acid phenylethylamide

C18H21NO (267.1623)


   

(2E,4E,6E,12Z)-2-Methylpropylamide-2,4,6,12-Tetradecatetraene-8,10-diynoic acid

(2E,4E,6E,12Z)-2-Methylpropylamide-2,4,6,12-Tetradecatetraene-8,10-diynoic acid

C18H21NO (267.1623)


   
   

3-[(5E)-5-methyl-4-oxo-2-hydroxy-5-octenyl]glutarimide

3-[(5E)-5-methyl-4-oxo-2-hydroxy-5-octenyl]glutarimide

C14H21NO4 (267.1471)


   

(2S,3S,5E,7E)-2-Amino-5,7-tetradecadien-3-ol

(2S,3S,5E,7E)-2-Amino-5,7-tetradecadien-3-ol

C16H29NO2 (267.2198)


   

Wasabidienone D

Wasabidienone D

C14H21NO4 (267.1471)


   

Pumiliotoxin 267C

Pumiliotoxin 267C

C16H29NO2 (267.2198)


   

raputimonoindole A

raputimonoindole A

C18H21NO (267.1623)


   

3-methyl-2-(2-pentylidene-cyclopropyl)-1H-quinolin-4-one

3-methyl-2-(2-pentylidene-cyclopropyl)-1H-quinolin-4-one

C18H21NO (267.1623)


   

Farinomalein C

Farinomalein C

C14H21NO4 (267.1471)


   

5,6,7,8-Tetramethoxy-2-methyl-1,2,3,4-tetrahydroisoquinoline

5,6,7,8-Tetramethoxy-2-methyl-1,2,3,4-tetrahydroisoquinoline

C14H21NO4 (267.1471)


   

5-Amino-2,6-dimethyl-6-hydroxy-4-(2-methylbutyryl)-3-methoxy-2,4-cyclohexadien-1-one

5-Amino-2,6-dimethyl-6-hydroxy-4-(2-methylbutyryl)-3-methoxy-2,4-cyclohexadien-1-one

C14H21NO4 (267.1471)


   

(4R*,5R*,7S*,10R*)-4-formamidoeudesman-11-ol

(4R*,5R*,7S*,10R*)-4-formamidoeudesman-11-ol

C16H29NO2 (267.2198)


   

5-Propyl-1-oxa-4-azacyclopentadec-10-en-15-one

5-Propyl-1-oxa-4-azacyclopentadec-10-en-15-one

C16H29NO2 (267.2198)


   

(E,E,E)-Pyrrolidide-2,4,12-Tetradecatriene-8,10-diynoic aci|tetradeca-2E,4E,12E-trien-8,10-diynoic acid pyrrolidide

(E,E,E)-Pyrrolidide-2,4,12-Tetradecatriene-8,10-diynoic aci|tetradeca-2E,4E,12E-trien-8,10-diynoic acid pyrrolidide

C18H21NO (267.1623)


   

3-Deoxy-3-methylaminoxylose-beta-D-Furanose-form-Me glycoside, 5-benzyl|3-Deoxy-3-methylaminoxylose-Me glycoside, 5-benzyl

3-Deoxy-3-methylaminoxylose-beta-D-Furanose-form-Me glycoside, 5-benzyl|3-Deoxy-3-methylaminoxylose-Me glycoside, 5-benzyl

C14H21NO4 (267.1471)


   
   

1,1-Dimethyl-2-[1-(hydroxymethyl)-2-hydroxyethyl]-1,2,3,4-tetrahydroisoquinoline-6,7-diol

1,1-Dimethyl-2-[1-(hydroxymethyl)-2-hydroxyethyl]-1,2,3,4-tetrahydroisoquinoline-6,7-diol

C14H21NO4 (267.1471)


   

scalusamide A

scalusamide A

C15H25NO3 (267.1834)


   

metoprolol

metoprolol

C15H25NO3 (267.1834)


C - Cardiovascular system > C07 - Beta blocking agents > C07A - Beta blocking agents > C07AB - Beta blocking agents, selective C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013565 - Sympatholytics D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents Metoprolol is a selective beta1 receptor blocker used in treatment of several diseases of the cardiovascular system. It is marketed under the brand name Lopressor by Novartis, and Toprol (in the USA); Seleken or Selokeen (elsewhere); A selective adrenergic beta-1-blocking agent with no stimulatory action. Its binding to plasma albumin is weaker than alprenolol and it may be useful in the treatment of several diseases of the cardiovascular system; Metoprolol is a selective beta1 receptor blocker used in treatment of several diseases of the cardiovascular system. It is marketed under the brand name Lopressor by Novartis, and Toprol (in the USA); Seleken or Selokeen (elsewhere); as Minax by Alphapharm (in Australia), as Betaloc by AstraZeneca and as Corvitol by Berlin-Chemie AG; A selective adrenergic beta-1-blocking agent with no stimulatory action. Its binding to plasma albumin is weaker than alprenolol and it may be useful in angina pectoris, hypertension, or cardiac arrhythmias; as Minax by Alphapharm (in Australia), as Betaloc by AstraZeneca and as Corvitol by Berlin-Chemie AG. [HMDB] CONFIDENCE standard compound; INTERNAL_ID 1107 CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 81 CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 1080 CONFIDENCE standard compound; INTERNAL_ID 4072 CONFIDENCE Reference Standard (Level 1) Metoprolol is an orally active, selective β1-adrenoceptor antagonist. Metoprolol shows anti-inflammation, antitumor and anti-angiogenic properties[1][2][3].

   

Atenolol acid

Metoprolol acid

C14H21NO4 (267.1471)


A monocarboxylic acid that is phenylacetic acid substituted by a 2-hydroxy-3-(propan-2-ylamino)propoxy group at position 4. It is a metabolite of the drug atenolol. CONFIDENCE standard compound; INTERNAL_ID 2025 CONFIDENCE standard compound; EAWAG_UCHEM_ID 697 EAWAG_UCHEM_ID 697; CONFIDENCE standard compound

   

BREVICARINE

NCGC00160349-01!BREVICARINE

C17H21N3 (267.1735)


   

(8S,Z)-6-((2R)-5-hydroxy-2-methylhexylidene)-8-methyloctahydroindolizin-8-ol

(8S,Z)-6-((2R)-5-hydroxy-2-methylhexylidene)-8-methyloctahydroindolizin-8-ol

C16H29NO2 (267.2198)


   

(7R,8R,E)-8-methyl-6-((R)-2-methylhexylidene)octahydroindolizine-7,8-diol

(7R,8R,E)-8-methyl-6-((R)-2-methylhexylidene)octahydroindolizine-7,8-diol

C16H29NO2 (267.2198)


   

(1S,Z)-3-((2R)-4-hydroxy-2-methylpentylidene)-1-methyloctahydro-2H-quinolizin-1-ol

(1S,Z)-3-((2R)-4-hydroxy-2-methylpentylidene)-1-methyloctahydro-2H-quinolizin-1-ol

C16H29NO2 (267.2198)


   

(1S,Z)-3-((2R)-5-hydroxy-2-methylhexylidene)octahydro-2H-quinolizin-1-ol

(1S,Z)-3-((2R)-5-hydroxy-2-methylhexylidene)octahydro-2H-quinolizin-1-ol

C16H29NO2 (267.2198)


   

(2R,5S)-2,5-di((E)-pent-2-en-4-yn-1-yl)decahydroquinoline

(2R,5S)-2,5-di((E)-pent-2-en-4-yn-1-yl)decahydroquinoline

C19H25N (267.1987)


   

3,5-Dicarbethoxy-1,4-dihydrocollidine

3,5-Dicarbethoxy-1,4-dihydrocollidine

C14H21NO4 (267.1471)


   

butyl prop-2-enoate,2-methylprop-2-enoic acid,prop-2-enenitrile

butyl prop-2-enoate,2-methylprop-2-enoic acid,prop-2-enenitrile

C14H21NO4 (267.1471)


   

2-(2H-benzotriazol-2-yl)-4-tert-butylphenol

2-(2H-benzotriazol-2-yl)-4-tert-butylphenol

C16H17N3O (267.1372)


   

2-BENZYL-2,2-DIMETHYLPROPIONANILIDE

2-BENZYL-2,2-DIMETHYLPROPIONANILIDE

C18H21NO (267.1623)


   

tert-Butyl 9-oxo-3-azaspiro[5.5]undecane-3-carboxylate

tert-Butyl 9-oxo-3-azaspiro[5.5]undecane-3-carboxylate

C15H25NO3 (267.1834)


   

1-[2-[4-(chloromethyl)phenoxy]ethyl]azepane

1-[2-[4-(chloromethyl)phenoxy]ethyl]azepane

C15H22ClNO (267.139)


   

Boronic acid, B-[3-fluoro-4-[3-(1-pyrrolidinyl)propoxy]phenyl]

Boronic acid, B-[3-fluoro-4-[3-(1-pyrrolidinyl)propoxy]phenyl]

C13H19BFNO3 (267.1442)


   

BOC-L-TYROSINOL

BOC-L-TYROSINOL

C14H21NO4 (267.1471)


   

N,N-bis[(4-methylphenyl)diazenyl]methanamine

N,N-bis[(4-methylphenyl)diazenyl]methanamine

C15H17N5 (267.1484)


   

2-Isopropyl-4-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)thiazole

2-Isopropyl-4-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)thiazole

C13H22BNO2S (267.1464)


   

1-[(dibenzylamino)methyl]cyclopropan-1-ol

1-[(dibenzylamino)methyl]cyclopropan-1-ol

C18H21NO (267.1623)


   
   

(-)-α,α-Diphenyl-N-methyl-D-prolinol

(-)-α,α-Diphenyl-N-methyl-D-prolinol

C18H21NO (267.1623)


   

3,5-DIMETHYL-1H-PYRROLE-2,4-DICARBOXYLICACID4-TERT-BUTYLESTER2-ETHYLESTER

3,5-DIMETHYL-1H-PYRROLE-2,4-DICARBOXYLICACID4-TERT-BUTYLESTER2-ETHYLESTER

C14H21NO4 (267.1471)


   

(1R,2S,5R)-5-Methyl-2-isopropylcyclohexyl 5-oxo-L-prolinate

(1R,2S,5R)-5-Methyl-2-isopropylcyclohexyl 5-oxo-L-prolinate

C15H25NO3 (267.1834)


   

4-[4-(3-chlorophenyl)piperazin-1-yl]butan-1-amine

4-[4-(3-chlorophenyl)piperazin-1-yl]butan-1-amine

C14H22ClN3 (267.1502)


   

(S)-5-methoxy-1,2,3,4-tetrahydro-N-(phenylmethyl)- 2-Naphthalenamine (Rotigotine)

(S)-5-methoxy-1,2,3,4-tetrahydro-N-(phenylmethyl)- 2-Naphthalenamine (Rotigotine)

C18H21NO (267.1623)


   

1-Adamantanamine fumarate

1-Adamantanamine fumarate

C14H21NO4 (267.1471)


   

4-Hydroxy-4-(1H-imidazol-4-yl)piperidine-1-carboxylic acid tert-butyl ester

4-Hydroxy-4-(1H-imidazol-4-yl)piperidine-1-carboxylic acid tert-butyl ester

C13H21N3O3 (267.1583)


   

Benzene,1,4-dibutoxy-2-nitro-

Benzene,1,4-dibutoxy-2-nitro-

C14H21NO4 (267.1471)


   

2-Butanone,4-[bis(phenylmethyl)amino]-

2-Butanone,4-[bis(phenylmethyl)amino]-

C18H21NO (267.1623)


   

3-(DIPHENYLMETHOXY)PIPERIDINE

3-(DIPHENYLMETHOXY)PIPERIDINE

C18H21NO (267.1623)


   

2-tert-Butyl 4-ethyl 3,5-dimethyl-1H-pyrrole-2,4-dicarboxylate

2-tert-Butyl 4-ethyl 3,5-dimethyl-1H-pyrrole-2,4-dicarboxylate

C14H21NO4 (267.1471)


   

vx.

O-Ethyl S-(2-diisopropylaminoethyl) methylphosphonothioate

C11H26NO2PS (267.1422)


D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D002800 - Cholinesterase Inhibitors D009676 - Noxae > D011042 - Poisons > D002619 - Chemical Warfare Agents D004791 - Enzyme Inhibitors

   

tert-butyl 4-(1,2,4-triazol-1-ylmethyl)piperazine-1-carboxylate

tert-butyl 4-(1,2,4-triazol-1-ylmethyl)piperazine-1-carboxylate

C12H21N5O2 (267.1695)


   

1-BENZYL-4-(4-FLUOROPHENYL)-1,2,3,6-TETRAHYDROPYRIDINE

1-BENZYL-4-(4-FLUOROPHENYL)-1,2,3,6-TETRAHYDROPYRIDINE

C18H18FN (267.1423)


   

(2S,3S)-(-)-2,3-BUTANEDIOLDI-P-TOSYLATE

(2S,3S)-(-)-2,3-BUTANEDIOLDI-P-TOSYLATE

C18H21NO (267.1623)


   

ethyl 3-cyano-3-(4-hydroxypiperidin-1-yl)pyrrolidine-1-carboxylate

ethyl 3-cyano-3-(4-hydroxypiperidin-1-yl)pyrrolidine-1-carboxylate

C13H21N3O3 (267.1583)


   

tert-Butyl 4-(5-aminoisoxazol-3-yl)piperidine-1-carboxylate

tert-Butyl 4-(5-aminoisoxazol-3-yl)piperidine-1-carboxylate

C13H21N3O3 (267.1583)


   

UNII:9D22C2BN68

UNII:9D22C2BN68

C15H25NO3 (267.1834)


   
   

Ethyl 2,4-dimethyl-5-(ethoxycarbonyl)-3-pyrrolepropionate

Ethyl 2,4-dimethyl-5-(ethoxycarbonyl)-3-pyrrolepropionate

C14H21NO4 (267.1471)


   

2-[(benzyl-methyl-amino)methyl]cyclohexan-1-one

2-[(benzyl-methyl-amino)methyl]cyclohexan-1-one

C15H22ClNO (267.139)


   

4-BENZHYDRYL-PIPERAZIN-1-YLAMINE

4-BENZHYDRYL-PIPERAZIN-1-YLAMINE

C17H21N3 (267.1735)


   

3-(5-AMINO-ISOXAZOL-3-YL)-PIPERIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER

3-(5-AMINO-ISOXAZOL-3-YL)-PIPERIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER

C13H21N3O3 (267.1583)


   

1-Benzyl-4-phenoxypiperidine

1-Benzyl-4-phenoxypiperidine

C18H21NO (267.1623)


   

N-ACETYL-O-AMINOAZOTOLUENE

N-ACETYL-O-AMINOAZOTOLUENE

C16H17N3O (267.1372)


   

tert-butyl 4-hydroxy-3-methoxyphenethylcarbamate

tert-butyl 4-hydroxy-3-methoxyphenethylcarbamate

C14H21NO4 (267.1471)


   

(S)-2-(Methoxydiphenylmethyl)pyrrolidine

(S)-2-(Methoxydiphenylmethyl)pyrrolidine

C18H21NO (267.1623)


   

[2-HYDROXY-2-(4-METHOXY-PHENYL)-ETHYL]-CARBAMIC ACID TERT-BUTYL ESTER

[2-HYDROXY-2-(4-METHOXY-PHENYL)-ETHYL]-CARBAMIC ACID TERT-BUTYL ESTER

C14H21NO4 (267.1471)


   

3-(3,4-dimethylphenyl)-1-propylpiperidine

3-(3,4-dimethylphenyl)-1-propylpiperidine

C16H26ClN (267.1754)


   

4Cl-PVP Research Powder

4Cl-PVP Research Powder

C15H22ClNO (267.139)


   

(2R)-2-[Methoxy(diphenyl)methyl]pyrrolidine

(2R)-2-[Methoxy(diphenyl)methyl]pyrrolidine

C18H21NO (267.1623)


   

1-Benzyl-4-phenyl-3-pyrrolidinemethanol

1-Benzyl-4-phenyl-3-pyrrolidinemethanol

C18H21NO (267.1623)


   

4-heptyl-N-phenylaniline

4-heptyl-N-phenylaniline

C19H25N (267.1987)


   

Aloisine A

4-(7-butyl-5H-pyrrolo[2,3-b]pyrazin-6-yl)phenol

C16H17N3O (267.1372)


   

2-(4-BENZYL-PIPERAZIN-1-YL)ANILINE

2-(4-BENZYL-PIPERAZIN-1-YL)ANILINE

C17H21N3 (267.1735)


   

7-(1-Pyrrolidinylmethyl)pyrrolo[1,2-a]quinoxalin-4(5H)-one

7-(1-Pyrrolidinylmethyl)pyrrolo[1,2-a]quinoxalin-4(5H)-one

C16H17N3O (267.1372)


   

2-(5-AMINO-ISOXAZOL-3-YL)-PIPERIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER

2-(5-AMINO-ISOXAZOL-3-YL)-PIPERIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER

C13H21N3O3 (267.1583)


   

2-(1-CYANOCYCLOHEXANE)DIETHYL-MALONATE

2-(1-CYANOCYCLOHEXANE)DIETHYL-MALONATE

C14H21NO4 (267.1471)


   

(S)-Metoprolol

(S)-Metoprolol

C15H25NO3 (267.1834)


   

(R)-Metoprolol

(R)-Metoprolol

C15H25NO3 (267.1834)


   

butyl prop-2-enoate,ethenyl acetate,prop-2-enenitrile

butyl prop-2-enoate,ethenyl acetate,prop-2-enenitrile

C14H21NO4 (267.1471)


   

N-cyclopentyl-2-methyl-5-(4-methylphenyl)pyrimidin-4-amine

N-cyclopentyl-2-methyl-5-(4-methylphenyl)pyrimidin-4-amine

C17H21N3 (267.1735)


   

N-cyclopentyl-2-methyl-5-(3-methylphenyl)pyrimidin-4-amine

N-cyclopentyl-2-methyl-5-(3-methylphenyl)pyrimidin-4-amine

C17H21N3 (267.1735)


   

4-(diethylaminomethyl)-2-methyl-5-(2-methylpropyl)furan-3-carboxylic acid

4-(diethylaminomethyl)-2-methyl-5-(2-methylpropyl)furan-3-carboxylic acid

C15H25NO3 (267.1834)


   

1-(Triisopropylsilyl)pyrrole-3-boronic acid

1-(Triisopropylsilyl)pyrrole-3-boronic acid

C13H26BNO2Si (267.1826)


   

1-Benzyl-4-phenyl-4-piperidinol

1-Benzyl-4-phenyl-4-piperidinol

C18H21NO (267.1623)


   

4-T-butyl-N-(4-isopropylphenyl)benzenamine

4-T-butyl-N-(4-isopropylphenyl)benzenamine

C19H25N (267.1987)


   

(4-Boc-1-piperazinium-1-ylmethyl)trifluoroborate internal salt

(4-Boc-1-piperazinium-1-ylmethyl)trifluoroborate internal salt

C10H19BF3N2O2 (267.1492)


   

2-[Benzyl(methyl)amino]-1-(4-methylphenyl)-1-propanone

2-[Benzyl(methyl)amino]-1-(4-methylphenyl)-1-propanone

C18H21NO (267.1623)


   

(3S,4S)-TERT-BUTYL4-(FURAN-3-YL)-3-HYDROXYPIPERIDINE-1-CARBOXYLATE

(3S,4S)-TERT-BUTYL4-(FURAN-3-YL)-3-HYDROXYPIPERIDINE-1-CARBOXYLATE

C14H21NO4 (267.1471)


   

1-(1-Adamantyl)-5-methyl-1,2,3,6-tetrahydropyridine hydrochloride

1-(1-Adamantyl)-5-methyl-1,2,3,6-tetrahydropyridine hydrochloride

C16H26ClN (267.1754)


   

Metoprolol impurity 1

Metoprolol impurity 1

C15H25NO3 (267.1834)


   

N-(methoxymethyl)-1-(4-methoxyphenyl)-N-(trimethylsilylmethyl)methanamine

N-(methoxymethyl)-1-(4-methoxyphenyl)-N-(trimethylsilylmethyl)methanamine

C14H25NO2Si (267.1654)


   

4-(4-benzylpiperazino)aniline

4-(4-benzylpiperazino)aniline

C17H21N3 (267.1735)


   

1,4-Benzenediamine,N4-[[4-(dimethylamino)phenyl]methylene]-N1,N1-dimethyl-

1,4-Benzenediamine,N4-[[4-(dimethylamino)phenyl]methylene]-N1,N1-dimethyl-

C17H21N3 (267.1735)


   

1-Boc-4-(5-Methyl-1,3,4-oxadiazol-2-yl)piperidine

1-Boc-4-(5-Methyl-1,3,4-oxadiazol-2-yl)piperidine

C13H21N3O3 (267.1583)


   

1-Benzyl-3-phenoxypiperidine

1-Benzyl-3-phenoxypiperidine

C18H21NO (267.1623)


   
   

N-benzyl-5-methoxy-1,2,3,4-tetrahydronaphthalen-2-amine

N-benzyl-5-methoxy-1,2,3,4-tetrahydronaphthalen-2-amine

C18H21NO (267.1623)


   
   

Cafaminol

Cafaminol

C11H17N5O3 (267.1331)


C78274 - Agent Affecting Cardiovascular System > C29707 - Vasodilating Agent

   

3-(5-Methyl-1H-imidazol-4-yl)-1-(1-methyl-1H-indol-3-yl)-1-propanone

3-(5-Methyl-1H-imidazol-4-yl)-1-(1-methyl-1H-indol-3-yl)-1-propanone

C16H17N3O (267.1372)


   

3,6-Bis(dimethylamino)xanthylium

3,6-Bis(dimethylamino)xanthylium

C17H19N2O+ (267.1497)


   

Mesityl(piperidin-4-yl)methanone hydrochloride

Mesityl(piperidin-4-yl)methanone hydrochloride

C15H22ClNO (267.139)


   

1H-Pyrazolo[3,4-d]pyrimidin-4-amine, 1-(1,1-dimethylethyl)-3-phenyl-

1H-Pyrazolo[3,4-d]pyrimidin-4-amine, 1-(1,1-dimethylethyl)-3-phenyl-

C15H17N5 (267.1484)


   

3-Hydroxy-4-hydroxymethyl-1-(4-oxo-4,4A,5,7A-tetrahydro-3H-pyrrolo[3,2-D]pyrimidin-7-ylmethyl)-pyrrolidinium

3-Hydroxy-4-hydroxymethyl-1-(4-oxo-4,4A,5,7A-tetrahydro-3H-pyrrolo[3,2-D]pyrimidin-7-ylmethyl)-pyrrolidinium

C12H19N4O3+ (267.1457)


   

(10Z)-Heptadecenoate

(10Z)-Heptadecenoate

C17H31O2- (267.2324)


A monounsaturated fatty acid anion that is the conjugate base of (10Z)-heptadecenoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

10-Heptadecenoate

10-Heptadecenoate

C17H31O2- (267.2324)


   

N-[3-(3-aminopropylamino)propyl]-2,3-dihydroxybenzamide

N-[3-(3-aminopropylamino)propyl]-2,3-dihydroxybenzamide

C13H21N3O3 (267.1583)


   

(2R)-2-[(1S,4R,4aS)-7-hydroperoxy-4,7-dimethyl-2,3,4,4a,5,6-hexahydro-1H-naphthalen-1-yl]propanoate

(2R)-2-[(1S,4R,4aS)-7-hydroperoxy-4,7-dimethyl-2,3,4,4a,5,6-hexahydro-1H-naphthalen-1-yl]propanoate

C15H23O4- (267.1596)


   

8beta-Hydroxy ilicate

8beta-Hydroxy ilicate

C15H23O4- (267.1596)


   

(7Z)-10-methyl-hexadec-7-enoate

(7Z)-10-methyl-hexadec-7-enoate

C17H31O2- (267.2324)


   

8-(2-Hexylcyclopropyl)octanoate

8-(2-Hexylcyclopropyl)octanoate

C17H31O2- (267.2324)


   

Morpholin-4-yl(4-pentylcyclohexyl)methanone

Morpholin-4-yl(4-pentylcyclohexyl)methanone

C16H29NO2 (267.2198)


   

1-Cyclohexyl-2,3-dihydropyrrolo[2,3-b]quinolin-4-amine

1-Cyclohexyl-2,3-dihydropyrrolo[2,3-b]quinolin-4-amine

C17H21N3 (267.1735)


   

N-tert-butyl-1-phenyl-4-pyrazolo[3,4-d]pyrimidinamine

N-tert-butyl-1-phenyl-4-pyrazolo[3,4-d]pyrimidinamine

C15H17N5 (267.1484)


   

6-[(4-Methoxyphenyl)methyl]-3-methyl-5,6,7,8-tetrahydroquinoline

6-[(4-Methoxyphenyl)methyl]-3-methyl-5,6,7,8-tetrahydroquinoline

C18H21NO (267.1623)


   

2-(2-Ethoxyphenyl)-5,6-dimethyl-1,3-dihydroisoindole

2-(2-Ethoxyphenyl)-5,6-dimethyl-1,3-dihydroisoindole

C18H21NO (267.1623)


   

3-(1-hydroxy-5,5-dimethyl-4-phenyl-2H-imidazol-2-yl)pyridine

3-(1-hydroxy-5,5-dimethyl-4-phenyl-2H-imidazol-2-yl)pyridine

C16H17N3O (267.1372)


   

4-(Methoxymethyl)-6-methyl-2-(2-methylanilino)-3-pyridinecarbonitrile

4-(Methoxymethyl)-6-methyl-2-(2-methylanilino)-3-pyridinecarbonitrile

C16H17N3O (267.1372)


   

1-Methyl-2-[(4-methyl-1-piperidinyl)methyl]-3-indolecarbonitrile

1-Methyl-2-[(4-methyl-1-piperidinyl)methyl]-3-indolecarbonitrile

C17H21N3 (267.1735)


   

(E,2E)-N-(1,2,4-Triazol-4-yl)-2-(1,3,3-trimethylindol-2-ylidene)ethanimine

(E,2E)-N-(1,2,4-Triazol-4-yl)-2-(1,3,3-trimethylindol-2-ylidene)ethanimine

C15H17N5 (267.1484)


   

N-[(E)-1-Cyclopropylethylideneamino]-2-pyrrol-1-ylbenzamide

N-[(E)-1-Cyclopropylethylideneamino]-2-pyrrol-1-ylbenzamide

C16H17N3O (267.1372)


   

(S)-3-(indol-3-ylmethyl)-6,7,8,8a-tetrahydropyrrolo[1,2-a]pyrazin-1-one

(S)-3-(indol-3-ylmethyl)-6,7,8,8a-tetrahydropyrrolo[1,2-a]pyrazin-1-one

C16H17N3O (267.1372)


   

4-(4-Diethylaminostyryl)-1-methylpyridinium

4-(4-Diethylaminostyryl)-1-methylpyridinium

C18H23N2+ (267.1861)


   

N-ethyl-N-(4-ethylphenyl)-7H-purin-6-amine

N-ethyl-N-(4-ethylphenyl)-7H-purin-6-amine

C15H17N5 (267.1484)


   

2-methoxy-N-[(1-methyl-2-benzimidazolyl)methyl]aniline

2-methoxy-N-[(1-methyl-2-benzimidazolyl)methyl]aniline

C16H17N3O (267.1372)


   

(5-Methyl-2-propan-2-ylcyclohexyl) 2-oxopyrrolidine-1-carboxylate

(5-Methyl-2-propan-2-ylcyclohexyl) 2-oxopyrrolidine-1-carboxylate

C15H25NO3 (267.1834)


   

(E)-(3R)-3-Benzylamino-5-phenyl-4-pentenol

(E)-(3R)-3-Benzylamino-5-phenyl-4-pentenol

C18H21NO (267.1623)


   

N-[(Z)-dodec-2-enoyl]morpholine

N-[(Z)-dodec-2-enoyl]morpholine

C16H29NO2 (267.2198)


   

cis-9-Heptadecenoate

cis-9-Heptadecenoate

C17H31O2- (267.2324)


   

alpha-mycolate type-2 (III)

alpha-mycolate type-2 (III)

C16H27O3- (267.196)


   

8-[(1R,2S)-2-hexylcyclopropyl]octanoate

8-[(1R,2S)-2-hexylcyclopropyl]octanoate

C17H31O2- (267.2324)


   

4-Methoxy-N,N-bis-trimethylsilyl-aniline

4-Methoxy-N,N-bis-trimethylsilyl-aniline

C13H25NOSi2 (267.1475)


   

Yellow pyoctanine

Yellow pyoctanine

C17H21N3 (267.1735)


D000890 - Anti-Infective Agents D004396 - Coloring Agents D004202 - Disinfectants

   

LYSERGAMIDE

LYSERGAMIDE

C16H17N3O (267.1372)


An ergoline alkaloid comprising ergoline lacking hydrogens at positions 9 and 10 and also having a methyl group attached to the piperidine nitrogen.

   

Elaeocarpidine

Elaeocarpidine

C17H21N3 (267.1735)


   

Carbuterol

[5-[2-(tert-butylamino)-1-hydroxyethyl]-2-hydroxyphenyl]urea

C13H21N3O3 (267.1583)


R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03C - Adrenergics for systemic use > R03CC - Selective beta-2-adrenoreceptor agonists R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03A - Adrenergics, inhalants > R03AC - Selective beta-2-adrenoreceptor agonists C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist

   

Diethyl 1,4-dihydro-2,4,6-trimethyl-3,5-pyridinedicarboxylate

3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,4,6-trimethyl-, diethyl ester

C14H21NO4 (267.1471)


   

(9Z)-Heptadecenoate

(9Z)-Heptadecenoate

C17H31O2 (267.2324)


A monounsaturated fatty acid anion that is the conjugate base of (9Z)-heptadecenoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   
   

2-(nona-1,3-dien-1-yl)-3h-quinolin-4-one

2-(nona-1,3-dien-1-yl)-3h-quinolin-4-one

C18H21NO (267.1623)


   

6-hydroxy-1-(5-hydroxyhex-1-en-1-yl)-8-methyl-1h,5h,6h,8ah-[1,3]oxazolo[3,4-a]pyridin-3-one

6-hydroxy-1-(5-hydroxyhex-1-en-1-yl)-8-methyl-1h,5h,6h,8ah-[1,3]oxazolo[3,4-a]pyridin-3-one

C14H21NO4 (267.1471)


   

(4s,7r)-6-methyl-6,11-diazatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),2,9,12,14-pentaene-4-carboximidic acid

(4s,7r)-6-methyl-6,11-diazatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),2,9,12,14-pentaene-4-carboximidic acid

C16H17N3O (267.1372)


   

4-(4-isopropylbenzoyl)-n,n-dimethylaniline

4-(4-isopropylbenzoyl)-n,n-dimethylaniline

C18H21NO (267.1623)


   

3-{[(2r)-3,3-dimethyloxiran-2-yl]methyl}-5-[(1e)-3-methylbuta-1,3-dien-1-yl]-1h-indole

3-{[(2r)-3,3-dimethyloxiran-2-yl]methyl}-5-[(1e)-3-methylbuta-1,3-dien-1-yl]-1h-indole

C18H21NO (267.1623)


   

6,7-dihydroxy-1,1-dimethyl-n-(2'-glyceryl)-1,2,3,4-tetrahydroisoquinoline

NA

C14H21NO4 (267.1471)


{"Ingredient_id": "HBIN012059","Ingredient_name": "6,7-dihydroxy-1,1-dimethyl-n-(2'-glyceryl)-1,2,3,4-tetrahydroisoquinoline","Alias": "NA","Ingredient_formula": "C14H21NO4","Ingredient_Smile": "CC1(C2=CC(=C(C=C2CCN1C(CO)CO)O)O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "5854","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

5-(3,4-dimethoxyphenyl)-1,3-dimethylpyrrolidine-2,4-diol

5-(3,4-dimethoxyphenyl)-1,3-dimethylpyrrolidine-2,4-diol

C14H21NO4 (267.1471)


   

5-[3-(3-methylbut-2-en-1-yl)-4-methylideneoxolan-2-yl]-1h-indole

5-[3-(3-methylbut-2-en-1-yl)-4-methylideneoxolan-2-yl]-1h-indole

C18H21NO (267.1623)


   

3-[(3,3-dimethyloxiran-2-yl)methyl]-5-(3-methylbuta-1,3-dien-1-yl)-1h-indole

3-[(3,3-dimethyloxiran-2-yl)methyl]-5-(3-methylbuta-1,3-dien-1-yl)-1h-indole

C18H21NO (267.1623)


   

1-(2-hydroxypyrrolidin-1-yl)-2-methyldec-8-ene-1,3-dione

1-(2-hydroxypyrrolidin-1-yl)-2-methyldec-8-ene-1,3-dione

C15H25NO3 (267.1834)


   

2-(nona-3,6-dien-1-yl)-1h-quinolin-4-one

2-(nona-3,6-dien-1-yl)-1h-quinolin-4-one

C18H21NO (267.1623)


   

(2z,8z)-n-(2-phenylethyl)deca-2,8-dien-6-ynimidic acid

(2z,8z)-n-(2-phenylethyl)deca-2,8-dien-6-ynimidic acid

C18H21NO (267.1623)


   

(2e,4e,12e)-1-(pyrrolidin-1-yl)tetradeca-2,4,12-trien-8,10-diyn-1-one

(2e,4e,12e)-1-(pyrrolidin-1-yl)tetradeca-2,4,12-trien-8,10-diyn-1-one

C18H21NO (267.1623)


   

n-(2-phenylethyl)deca-2,8-dien-6-ynimidic acid

n-(2-phenylethyl)deca-2,8-dien-6-ynimidic acid

C18H21NO (267.1623)


   
   

(5s,10z)-5-propyl-1-oxa-4-azacyclopentadec-10-en-15-one

(5s,10z)-5-propyl-1-oxa-4-azacyclopentadec-10-en-15-one

C16H29NO2 (267.2198)


   

(6r)-5-amino-6-hydroxy-3-methoxy-2,6-dimethyl-4-[(2r)-2-methylbutanoyl]cyclohexa-2,4-dien-1-one

(6r)-5-amino-6-hydroxy-3-methoxy-2,6-dimethyl-4-[(2r)-2-methylbutanoyl]cyclohexa-2,4-dien-1-one

C14H21NO4 (267.1471)


   

n-(3-{9h-pyrido[3,4-b]indol-1-yl}propyl)guanidine

n-(3-{9h-pyrido[3,4-b]indol-1-yl}propyl)guanidine

C15H17N5 (267.1484)


   

2-[(3z,6z)-nona-3,6-dien-1-yl]-1h-quinolin-4-one

2-[(3z,6z)-nona-3,6-dien-1-yl]-1h-quinolin-4-one

C18H21NO (267.1623)


   

1-(pyrrolidin-1-yl)tetradeca-2,4,12-trien-8,10-diyn-1-one

1-(pyrrolidin-1-yl)tetradeca-2,4,12-trien-8,10-diyn-1-one

C18H21NO (267.1623)


   

(2r,8e)-1-[(2r)-2-hydroxypyrrolidin-1-yl]-2-methyldec-8-ene-1,3-dione

(2r,8e)-1-[(2r)-2-hydroxypyrrolidin-1-yl]-2-methyldec-8-ene-1,3-dione

C15H25NO3 (267.1834)


   

(2r,3r,4s,5s)-5-(3,4-dimethoxyphenyl)-1,3-dimethylpyrrolidine-2,4-diol

(2r,3r,4s,5s)-5-(3,4-dimethoxyphenyl)-1,3-dimethylpyrrolidine-2,4-diol

C14H21NO4 (267.1471)


   

6-hydroxy-3-[(5e)-2-hydroxy-5-methyl-4-oxooct-5-en-1-yl]-4,5-dihydro-3h-pyridin-2-one

6-hydroxy-3-[(5e)-2-hydroxy-5-methyl-4-oxooct-5-en-1-yl]-4,5-dihydro-3h-pyridin-2-one

C14H21NO4 (267.1471)


   

(2s,3r,4s)-3-methyl-7-methylidene-2-pentyl-2h,4h-pyrano[2,3-c]pyrrole-3,4,5-triol

(2s,3r,4s)-3-methyl-7-methylidene-2-pentyl-2h,4h-pyrano[2,3-c]pyrrole-3,4,5-triol

C14H21NO4 (267.1471)


   

5-amino-6-hydroxy-3-methoxy-2,6-dimethyl-4-(2-methylbutanoyl)cyclohexa-2,4-dien-1-one

5-amino-6-hydroxy-3-methoxy-2,6-dimethyl-4-(2-methylbutanoyl)cyclohexa-2,4-dien-1-one

C14H21NO4 (267.1471)


   

(2e,4e,6e,12z)-n-(2-methylpropyl)tetradeca-2,4,6,12-tetraen-8,10-diynimidic acid

(2e,4e,6e,12z)-n-(2-methylpropyl)tetradeca-2,4,6,12-tetraen-8,10-diynimidic acid

C18H21NO (267.1623)


   

(2s,4e)-5-hydroxy-4-(1-hydroxydecylidene)-2-methyl-2h-pyrrol-3-one

(2s,4e)-5-hydroxy-4-(1-hydroxydecylidene)-2-methyl-2h-pyrrol-3-one

C15H25NO3 (267.1834)


   

6-hydroxy-4-[(5e)-2-hydroxy-5-methyl-4-oxooct-5-en-1-yl]-4,5-dihydro-3h-pyridin-2-one

6-hydroxy-4-[(5e)-2-hydroxy-5-methyl-4-oxooct-5-en-1-yl]-4,5-dihydro-3h-pyridin-2-one

C14H21NO4 (267.1471)


   

6-hydroxy-3-(2-hydroxy-5-methyl-4-oxooct-5-en-1-yl)-4,5-dihydro-3h-pyridin-2-one

6-hydroxy-3-(2-hydroxy-5-methyl-4-oxooct-5-en-1-yl)-4,5-dihydro-3h-pyridin-2-one

C14H21NO4 (267.1471)


   

6-methyl-6,11-diazatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),2,9,12,14-pentaene-4-carboximidic acid

6-methyl-6,11-diazatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),2,9,12,14-pentaene-4-carboximidic acid

C16H17N3O (267.1372)


   

(1r,6r,8as)-6-hydroxy-1-[(1e,5r)-5-hydroxyhex-1-en-1-yl]-8-methyl-1h,5h,6h,8ah-[1,3]oxazolo[3,4-a]pyridin-3-one

(1r,6r,8as)-6-hydroxy-1-[(1e,5r)-5-hydroxyhex-1-en-1-yl]-8-methyl-1h,5h,6h,8ah-[1,3]oxazolo[3,4-a]pyridin-3-one

C14H21NO4 (267.1471)


   

methyl(4-{1-methyl-9h-pyrido[3,4-b]indol-4-yl}butyl)amine

methyl(4-{1-methyl-9h-pyrido[3,4-b]indol-4-yl}butyl)amine

C17H21N3 (267.1735)


   

(2e,4e,6z,12z)-n-(2-methylpropyl)tetradeca-2,4,6,12-tetraen-8,10-diynimidic acid

(2e,4e,6z,12z)-n-(2-methylpropyl)tetradeca-2,4,6,12-tetraen-8,10-diynimidic acid

C18H21NO (267.1623)


   

2-(3,4-dimethoxyphenyl)-1,5-dimethylpyrrolidine-3,4-diol

2-(3,4-dimethoxyphenyl)-1,5-dimethylpyrrolidine-3,4-diol

C14H21NO4 (267.1471)


   

2-[(3e,6e)-nona-3,6-dien-1-yl]-1h-quinolin-4-one

2-[(3e,6e)-nona-3,6-dien-1-yl]-1h-quinolin-4-one

C18H21NO (267.1623)


   

5-[(2r,3r)-3-(3-methylbut-2-en-1-yl)-4-methylideneoxolan-2-yl]-1h-indole

5-[(2r,3r)-3-(3-methylbut-2-en-1-yl)-4-methylideneoxolan-2-yl]-1h-indole

C18H21NO (267.1623)


   

(2r,3r,4r,5s)-2-(3,4-dimethoxyphenyl)-1,5-dimethylpyrrolidine-3,4-diol

(2r,3r,4r,5s)-2-(3,4-dimethoxyphenyl)-1,5-dimethylpyrrolidine-3,4-diol

C14H21NO4 (267.1471)